Inhibition of acute leukemia with attenuated Salmonella typhimurium strain VNP20009
Acute leukemia is a common hematological malignancy. Despite recent promising progress, the prognosis of acute leukemia patients remains to be improved. New therapies are therefore still needed. Salmonella typhimurium has been shown to be highly effective as an anti-tumor agent in many solid cancer...
Main Authors: | Meirong Li, Mengmeng Lu, Yunhao Lai, Xindan Zhang, Yuyu Li, Ping Mao, Zhicheng Liang, Yunping Mu, Ying Lin, Allan Z. Zhao, Zhenggang Zhao, Sujin Zhou, Fanghong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332220306181 |
Similar Items
-
Novel Perspectives on the Utilization of Chemotactic Salmonella Typhimurium VNP20009 as an Anticancer Agent
by: Broadway, Katherine Marie
Published: (2018) -
Therapeutic Effect of Recombinant Salmonella VNP20009-M on Osteosarcoma
by: ZHANG Xindan, et al.
Published: (2020-12-01) -
Bacterial delivery of the anti-tumor azurin-like protein Laz to glioblastoma cells
by: Manar Mansour, et al.
Published: (2020-03-01) -
Bacterial Carriers for Glioblastoma Therapy
by: Nalini Mehta, et al.
Published: (2017-03-01) -
Efficacy of living attenuated Salmonella typhimurium vaccine in poultry
by: Hanan M. Ibrahim, et al.
Published: (2010-12-01)